Work Here?
Novasign
Work Here?
AI-powered bioprocess optimization software and consulting
Novasign
Work Here?
AI-powered bioprocess optimization software and consulting
Overview
Novasign provides software and consulting to speed bioprocess development. Its core product, Novasign Studio, uses AI and hybrid modeling to build digital twins that combine process engineering knowledge with historical data to predict performance and product quality, enabling virtual experiments and reducing lab testing by 35% to 70% without requiring coding. It differentiates itself through a user-friendly platform that lets non-experts build and use digital twins, pairing software with hands-on consulting and training, along with a SaaS Hybrid Modeling Toolbox. The goal is to shorten development timelines, lower costs, and improve process understanding while pursuing international growth and strategic partnerships.
About Novasign
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Biotechnology
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
Austria
Founded
2019
Get referred to Novasign
See people who can refer or advise you
Simplify's Take
What believers are saying
- Repligen's July 2025 investment funds international scaling, especially U.S. market entry.
- NurExone's July 2026 collaboration validates Novasign on commercial exosome manufacturing.
- Novasign posted multiple Vienna openings in 2025 and 2026, showing active product buildout.
What critics are saying
- Novasign still relies on strategic partners; Repligen controls expansion leverage after July 2025.
- Hiring senior marketing and founding sales roles in 2026 signals commercialization remains unfinished.
- A failed U.S. rollout after Repligen's investment would expose Novasign as a niche Vienna consultancy.
What makes Novasign unique
- Repligen is integrating Novasign's digital twin capabilities into filtration systems since July 2025.
- Novasign Studio targets non-programmers, pairing AI with hybrid modeling for bioprocess optimization.
- NurExone chose Novasign in July 2026 for exosome process optimization and tech transfer.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Hybrid Work Options
Performance Bonus
Paid Holidays
Growth & Insights
6 month growth
↑ 15%1 year growth
↑ 15%2 year growth
↑ 27%There are no jobs for Novasign right now.
Find jobs on Simplify and start your career today
About Novasign
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Biotechnology
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
Austria
Founded
2019
There are no jobs for Novasign right now.
Find jobs on Simplify and start your career today